SHAPIRO ROBERT N - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHAPIRO ROBERT N ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$7,134,000
+13.3%
465,644
-4.2%
1.42%
+19.2%
Q3 2014$6,296,000
-15.5%
485,9740.0%1.20%
-15.5%
Q2 2014$7,450,000
-28.1%
485,974
-42.2%
1.42%
-26.0%
Q1 2014$10,360,000
+6.1%
840,9140.0%1.91%
+9.5%
Q4 2013$9,763,000
-1.9%
840,9140.0%1.75%
-0.6%
Q3 2013$9,956,000
+19.2%
840,9140.0%1.76%
+0.2%
Q2 2013$8,350,000840,9141.75%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders